Alternative activation of macrophages in human peritoneum: Implications for peritoneal fibrosis

Nephrology Dialysis Transplantation

Volumn 26, Issue 9, 2011, Pages 2995-3005

  Bellón, Teresa ^a   Martínez, Virginia ^a   Lucendo, Baltasar ^a   Del Peso, Gloria ^a   Castro, María José ^a   Aroeira, Luiz S ^a   Rodríguez Sanz, Aranzazu ^a   Ossorio, Marta ^a   Sánchez Villanueva, Rafael ^a   Selgas, Rafael ^a   Bajo, María Auxiliadora ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

CCL18; M2; macrophages; peritoneal dialysis; peritoneum

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; CREATININE; DIALYSIS FLUID; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 10; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCLEROSING PERITONITIS; STRESS; SUPERNATANT;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHEMOKINES, CC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONEUM; PERITONITIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 79959374455     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq771     Document Type: Article

References (51)

1. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969
2. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176: 287-292
3. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35 (Pubitemid 37328697)
4. Noorman F, Braat EA, Barrett-Bergshoeff M et al. Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages. J Leukoc Biol 1997; 61: 63-72 (Pubitemid 27079468)
5. Goerdt S, Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137-142 (Pubitemid 29115619)
6. Fadok VA, Bratton DL, Konowal A et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898 (Pubitemid 28096086)
7. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007; 37: 14-16 (Pubitemid 46128780)
8. Högger P, Dreier J, Droste A et al. Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoidinducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 1998; 161: 1883-1890 (Pubitemid 28387610)
9. Vercelli D, Jabara HH, Lee BW et al. Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. J Exp Med 1988; 167: 1406-1416
10. Puig-Kröger A, Serrano-Gómez D, Caparrós E et al. Regulated expression of the pathogen receptor dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin in THP-1 human leukemic cells, monocytes, and macrophages. J Biol Chem 2004; 279: 25680-25688 (Pubitemid 38756831)
11. Lee CG, Homer RJ, Zhu Z et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001; 194: 809-821 (Pubitemid 32983016)
12. Katakura T, Miyazaki M, Kobayashi M et al. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 2004; 172: 1407-1413 (Pubitemid 38116782)
13. Kodelja V,Müller C, Politz O et al. Alternative macrophage activationassociated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998; 160: 1411-1418 (Pubitemid 28093442)
14. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453-461 (Pubitemid 351599757)
15. Kodelja V, Muller C, Tenorio S et al. Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology 1997; 197: 478-493 (Pubitemid 27489996)
16. Gratchev A, Guillot P, Hakiy N et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001; 53: 386-392 (Pubitemid 32275696)
17. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594
18. Prasse A, Pechkovsky DV, Toews GB et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006; 173: 781-792
19. Prasse A, Pechkovsky DV, Toews GB et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum 2007; 56: 1685-1693 (Pubitemid 46764100)
20. Stout RD, Jiang C, Matta B et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342-349 (Pubitemid 40884337)
21. Noël W, Raes G, Ghassabeh GH et al. Alternatively activated macrophages during parasite infections. Trends Parasitol 2004; 20: 126-133 (Pubitemid 38264445)
22. Pardo A, Smith KM, Abrams J et al. CCL18/DC-CK-1/PARC upregulation in hypersensitivity pneumonitis. J Leukoc Biol 2001; 70: 610-616
23. Duffield JS, Forbes SJ, Constandinou CM et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65 (Pubitemid 40385505)
24. Kämmerer U, Eggert AO, Kapp M et al. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol 2003; 162: 887-896 (Pubitemid 36237496)
25. Gustafsson C, Mjösberg J, Matussek A et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008; 3: e2078
26. Mantovani A, Sozzani S, Locati M et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555 (Pubitemid 35223554)
27. Selgas R, Fernández-Reyes MJ, Bosque E et al. Functional longevity of the human peritoneum: how long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study. Am J Kidney Dis 1994; 23: 64-73 (Pubitemid 24021750)
28. Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341-356 (Pubitemid 29004273)
29. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530-541 (Pubitemid 37527296)
30. Yánez-Mó M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413 (Pubitemid 36159357)
31. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63: 1530-1539 (Pubitemid 36350019)
32. Aroeira LS, Aguilera A, Sanchez-Tomero JA et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18: 2004-2013 (Pubitemid 47041064)
33. Yokoyama T, Nitta K, Futatsuyama K et al. Identification of T helper cell subsets in continuous ambulatory peritoneal dialysis patients. Nephron 2001; 89: 215-218 (Pubitemid 32830612)
34. Song E, Ouyang N, Horbelt M et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000; 204: 19-28
35. Sánchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Sune C. Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol Cell Biol 2006; 26: 4998-5014 (Pubitemid 43955814)
36. Kim SS, Gwak SJ, Choi CY, Kim BS. Skin regeneration using keratinocytes and dermal fibroblasts cultured on biodegradable microspherical polymer scaffolds. J Biomed Mater Res B Appl Biomater 2005; 75: 369-377 (Pubitemid 41609558)
37. Leung JC, Chan LY, Tam KY et al. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 458-469
38. Sayós J, Martinez-Barriocanal A, Kitzig F et al. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem Biophys Res Commun 2004; 324: 640-647 (Pubitemid 39345564)
39. Mujais S, Nolph K, Gokal R et al. Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000; 20 (Suppl 4): S5-S21
40. Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation 1999; 23: 131-139 (Pubitemid 29178601)
41. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14: 163-176 (Pubitemid 30070982)
42. Wahl SM, Allen JB, Weeks BS et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc Natl Acad Sci USA 1993; 90: 4577-4581 (Pubitemid 23148948)
43. Xu W, Schlagwein N, Roos A et al. Human peritoneal macrophages show functional characteristics of M-CSF-driven anti-inflammatory type 2 macrophages. Eur J Immunol 2007; 37: 1594-1599 (Pubitemid 46939494)
44. Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 2002; 168: 1968-1977 (Pubitemid 34135800)
45. Lu Y, Hylander B, Brauner A. Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 1996; 16: 607-612 (Pubitemid 127541301)
46. Adema GJ, Hartgers F, Verstraten R et al. A dendritic-cell-derived CC chemokine that preferentially attracts naive T cells. Nature 1997; 387: 713-717 (Pubitemid 27270612)
47. Tiemessen MM, Jagger AL, Evans HG et al. CD41CD251Foxp31 regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 2007; 104: 19446-19451
48. Schutyser E, Richmond A, Van Damme J. Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes. J Leukoc Biol 2005; 78: 14-26 (Pubitemid 40979939)
49. Auer J, Blass M, Schulze-Koops H et al. Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis. Arthritis Res Ther 2007; 9: R94
50. Prasse A, Probst C, Bargagli E et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179: 717-723
51. Ahmad S, North BV, Qureshi A et al. CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis. Eur J Clin Invest 2010; 40: 1067-1073